F.D.A. Asks If Faulty Blood Monitor Tainted Xarelto Approval
Tuesday, February 23, 2016 - 02:00
in Psychology & Sociology
A legal brief says Johnson & Johnson has been asked whether Alere’s recalled INRatio blood-testing monitor compromised the anticlotting drug’s trial.